Litcius/Paper detail

Design, synthesis and bioevaluation of novel 6-substituted aminoindazole derivatives as anticancer agents

Ngo Xuan Hoang, Van-Hai Hoang, Thi-Thu-Trang Luu, Hung N. Luu, Thien Ngo, Duong Van Hieu, Nguyen Huu Long, Le Viet Anh, Sơn Tùng Ngô, Yen Thi Kim Nguyen, Byung Woo Han, Thanh X. Nguyen, Dinh Thi Thanh Hai, Trần Thị Thu Hiền, Phuong‐Thao Tran

2020RSC Advances12 citationsDOIOpen Access PDF

Abstract

value of 0.4 ± 0.3 μM in human colorectal cancer cells (HCT116). This compound also remarkably suppressed the IDO1 protein expression. In the cell-cycle studies, the suppressive activity of compound 36 in HCT116 cells was related to the G2/M cell cycle arrest. Altogether, the current findings demonstrate that compound 36 would be promising for further development as a potential anticancer agent.

Topics & Concepts

Combinatorial chemistryChemistrySeries (stratigraphy)StereochemistryBiologyPaleontologyTryptophan and brain disordersSynthesis and biological activityGenomics, phytochemicals, and oxidative stress
Design, synthesis and bioevaluation of novel 6-substituted aminoindazole derivatives as anticancer agents | Litcius